Equities

Ortivus AB

Ortivus AB

Actions
Health CareMedical Equipment and Services
  • Price (SEK)1.71
  • Today's Change0.01 / 0.59%
  • Shares traded12.77k
  • 1 Year change-25.00%
  • Beta0.4917
Data delayed at least 15 minutes, as of Sep 20 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1.290.1122
Total Receivables, Net173922
Total Inventory12--4.78
Prepaid expenses8.390.656.23
Other current assets, total------
Total current assets394055
Property, plant & equipment, net5.7905.45
Goodwill, net------
Intangibles, net24012
Long term investments4.0060--
Note receivable - long term------
Other long term assets------
Total assets7310072
LIABILITIES
Accounts payable9.030.932.86
Accrued expenses151.0116
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.91171.27
Other current liabilities, total170.2011
Total current liabilities421931
Total long term debt3.5702.04
Total debt5.48173.31
Deferred income tax------
Minority interest------
Other liabilities, total9.60--10
Total liabilities551943
SHAREHOLDERS EQUITY
Common stock16--16
Additional paid-in capital33--33
Retained earnings (accumulated deficit)(32)--(19)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.81810.60
Total equity178129
Total liabilities & shareholders' equity7310072
Total common shares outstanding444444
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.